Titelia

Holdings of Kalehua Capital Management LLC

21 declared positions · as of Mar 31, 2026

Original filing · Ten largest lines: 80 % of the equity sleeve

Sector breakdown

  • Unattributed 100.0 %

Titelia classification, company by company. The unattributed share stays visible.

Currency breakdown

  • USD 100.0 %

The quoted currency of each line, as declared.

Country breakdown

  • US 96.4 %
  • GB 3.6 %

Shares computed on the equity sleeve.

RankCountryLinesValueShare
1US20122.7M $96.44 %
2GB14.5M $3.56 %

Positions

RankCompanySharesValueWeight
1Alpha Architect 1-3 Month Box 218,27825.4M $
2X4 PHARMACEUTICALS INC 3,722,84015.4M $
3Surrozen Inc 385,17811.2M $
4VeraDermics Inc 145,6959.2M $
5Relay Therapeutics Inc 901,4579M $
6Sionna Therapeutics Inc 197,0727.9M $
7Aclaris Therapeutics Inc 1,832,3656.9M $
8Inhibikase Therapeutics Inc 3,821,8906.4M $
9Oruka Therapeutics Inc 118,5245.8M $
10Septerna Inc 194,5444.7M $
11Compass Pathways plc 819,6924.5M $
12LeonaBio Inc 393,7014M $
13DAMORA THERAPEUTICS INC 139,0003.6M $
14Gossamer Bio Inc 10,236,2933.4M $
15Tyra Biosciences Inc 74,4652.9M $
16PepGen Inc 1,000,0001.8M $
17Instil Bio Inc 183,0301.5M $
18Tenaya Therapeutics Inc 2,000,0001.4M $
19Korro Bio Inc 109,3761.2M $
20KALARIS THERAPEUTICS INC 135,585782.3K $
21LOOP INDUSTRIES INC 347,539361.4K $